Case Report

Accepted on 26 Dec 2024

Re-challenging Pralsetinib following Recovery from Pneumocystis jirovecii Pneumonia in a Lung Cancer Patient: A Case Report

in Respiratory Pharmacology

Zhe Zhao
Longbin Pang
Surui Liu
Ang Gao
Jie Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1443609

Editorial

Accepted on 23 Dec 2024

Editorial: Model Organisms in Respiratory Pharmacology

in Respiratory Pharmacology

Alexandra McCarron
Ranu Surolia
Livia Ruffini

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1540222

Original Research

Accepted on 20 Dec 2024

Unphysiological lung strain promotes ventilation-induced lung injury via activation of the PECAM-1/Src/STAT3 signaling pathway Authors

in Respiratory Pharmacology

Gang Liu
Binbin Dong
Zi-Heng Ding
Chao Lan
Changju Zhu
Qi Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1469783

Original Research

Accepted on 19 Dec 2024

High-risk adverse events in two types of single inhaler triple-therapy: a pharmacovigilance study based on the FAERS database

in Respiratory Pharmacology

Zhishen Ruan
Dan Li
Shasha Yuan
Yiling Fan
Bo Xu
Xiaodong Cong
Qing Miao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1460407

Original Research

Accepted on 30 Nov 2024

Mitigating Inflammation and Fibrosis: The Therapeutic Potential of Quercetin Liposomes in COPD

in Respiratory Pharmacology

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1503283

199 views

Original Research

Accepted on 16 Dec 2024

Uvaol attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells by modulating expression and membrane localization of β-catenin

in Respiratory Pharmacology

Liliane Patrícia Gonçalves Tenório
Felipe Xavier
Mônica Silveira Wagner
Kayo Moreira Bagri
Romulo G A Galvani
Claudia Mermelstein
Adriana Bonomo
Wilson Savino
Emiliano Barreto

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1504556

Original Research

Accepted on 16 Dec 2024

CD146 promotes resistance of NSCLC brain metastases to pemetrexed via the NF-κB signaling pathway

in Respiratory Pharmacology

Hao Qu
Yan Fang
Feng Zhang
Wenwen Liu
Shengkai Xia
Wenzhe Duan
Kun Zou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1502165

Review

Accepted on 11 Dec 2024

Mitochondrial quality control: a pathophysiological mechanism and potential therapeutic target for chronic obstructive pulmonary disease

in Respiratory Pharmacology

Mengjiao Xu
peng feng
jun yan
Lei Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1474310

Original Research

Accepted on 03 Dec 2024

A Novel Non-invasive Murine Model for Rapidly Testing Drug Activity via Inhalation Administration against Mycobacterium tuberculosis

in Respiratory Pharmacology

Xirong Tian
Gao Yamin
Wanli Ma
Jingran Zhang
Yanan Ju
Jie Ding
Sanshan Zeng
H.M. Adnan Hameed
Nanshan Zhong
Greg Cook

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1400436

Case Report

Published on 22 Nov 2024

Rare cancer with primary pleural epithelioid hemangioendothelioma diagnosed by thoracoscopic biopsy achieving disease control after 16 months: case report and literature review

in Respiratory Pharmacology

Ioannis S. Pateras
Konstantinos Kostopanagiotou
Menelaos G. Samaras
Anna Koumarianou
Mina Koutrouli
Nikolaos Korodimos
Katerina Kampoli
Vasiliki Apollonatou
Effrosyni Manali
Stylianos Loukides

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1482154

324 views

Review

Published on 13 Nov 2024

Pyroptosis in asthma: inflammatory phenotypes, immune and non-immune cells, and novel treatment approaches

in Respiratory Pharmacology

Yuqiu Hao
Wenrui Wang
Lin Zhang
Wei Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1452845

637 views

Original Research

Accepted on 11 Nov 2024

α-Bisabolol alleviates diesel exhaust particles-induced lung injury and mitochondrial dysfunction by regulating inflammatory, oxidative stress and apoptotic biomarkers through the c-Jun N-terminal kinase signalling pathway

in Respiratory Pharmacology

Sumaya Beegam
Nur E Zaaba
Ozaz Elzaki
Abderrahim Nemmar

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1485101

Review

Published on 08 Nov 2024

Bacteria and fungi of the lung: allies or enemies?

in Respiratory Pharmacology

Enrico Garaci
Marilena Pariano
Emilia Nunzi
Claudio Costantini
Marina Maria Bellet
Cinzia Antognelli
Matteo Antonio Russo
Luigina Romani

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1497173

393 views

Case Report

Published on 07 Nov 2024

Characteristics of voriconazole-induced visual disturbances and hallucinations: case reports and literature review

in Respiratory Pharmacology

Ya Liu
Ying Huang
Xiang Liu
Danxia Wang
Yixiang Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1420046

487 views

Original Research

Published on 28 Oct 2024

Therapeutic targets for lung cancer: genome-wide Mendelian randomization and colocalization analyses

in Respiratory Pharmacology

Yi Luan
Desheng Xian
Changwen Zhao
Xin Qing
Hanlin He
Kaixuan Zheng
Wenjun Song
Taijiao Jiang
Wenjian Wang
Chaohui Duan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1441233

940 views

Correction

Published on 25 Oct 2024

Corrigendum: CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder

in Respiratory Pharmacology

Cataldo Martucci
Andrew Dennis Allen
Nadia Moretto
Valentina Bagnacani
Alessandro Fioni
Riccardo Patacchini
Maurizio Civelli
Gino Villetti
Fabrizio Facchinetti

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1497520

266 views

Navigation group

Articles

Re-challenging Pralsetinib following Recovery from Pneumocystis jirovecii Pneumonia in a Lung Cancer Patient: A Case Report

Editorial: Model Organisms in Respiratory Pharmacology

Unphysiological lung strain promotes ventilation-induced lung injury via activation of the PECAM-1/Src/STAT3 signaling pathway Authors

High-risk adverse events in two types of single inhaler triple-therapy: a pharmacovigilance study based on the FAERS database

Mitigating Inflammation and Fibrosis: The Therapeutic Potential of Quercetin Liposomes in COPD

Uvaol attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells by modulating expression and membrane localization of β-catenin

CD146 promotes resistance of NSCLC brain metastases to pemetrexed via the NF-κB signaling pathway

Mitochondrial quality control: a pathophysiological mechanism and potential therapeutic target for chronic obstructive pulmonary disease

A Novel Non-invasive Murine Model for Rapidly Testing Drug Activity via Inhalation Administration against Mycobacterium tuberculosis

Rare cancer with primary pleural epithelioid hemangioendothelioma diagnosed by thoracoscopic biopsy achieving disease control after 16 months: case report and literature review

Pyroptosis in asthma: inflammatory phenotypes, immune and non-immune cells, and novel treatment approaches

α-Bisabolol alleviates diesel exhaust particles-induced lung injury and mitochondrial dysfunction by regulating inflammatory, oxidative stress and apoptotic biomarkers through the c-Jun N-terminal kinase signalling pathway

Bacteria and fungi of the lung: allies or enemies?

Characteristics of voriconazole-induced visual disturbances and hallucinations: case reports and literature review

Therapeutic targets for lung cancer: genome-wide Mendelian randomization and colocalization analyses

Corrigendum: CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder